EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

Evaluasi kuantitatif penggunaan antipsikotik pada pasien skizofrenia dengan metode ATC/DDD dan DU 90% di RSJ Tampan Provinsi Riau tahun 2023

Novia Sinata, Defrika Dian Tami, Erniza Pratiwi

Jurnal SAGO Gizi dan Kesehatan · 07.08.2026 · 7 (2) · 412

DOI: 10.30867/gikes.v7i2.3004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jurnal SAGO Gizi dan Kesehatan, online erschienen am 07.08.2026. Verfasst von Novia Sinata und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Schizophrenia is a major cause of disability, and antipsychotics are the main pharmacological treatment. Their use requires evaluation because adverse effects may affect treatment safety and adherence. Antipsychotic utilization among inpatients at RSJ Tampan has not previously been evaluated using the World Health Organization (WHO) ATC/DDD and DU 90% methods.

Objectives

This study aimed to quantitatively evaluate antipsychotic utilization among inpatients with schizophrenia using the ATC/DDD and DU 90% methods.

Methods

This descriptive observational study used a retrospective review of medical records from January to December 2023. A total of 101 records that met the eligibility criteria were selected through purposive sampling. Antipsychotic utilization was calculated as defined daily doses (DDD) per 100 bed-days. Drugs were ranked by utilization volume, and cumulative percentages were used to identify the DU 90% segment.

Results

Total antipsychotic utilization was 123.82 DDD/100 bed-days and was dominated by typical antipsychotics. Five drugs comprised the DU 90% segment: haloperidol (74.58 DDD/100 bed-days; 60.23%), risperidone (14.95; 12.07%), aripiprazole (14.42; 11.65%), fluphenazine (5.36; 4.33%), and trifluoperazine (4.73; 3.82%), with a cumulative proportion of 92.10%.

Conclusion

Antipsychotic utilization was concentrated in five drugs, with haloperidol accounting for the largest proportion. These quantitative findings support further evaluation of prescribing appropriateness and treatment safety.

Zitieren

APA

Sinata, N., Tami, D. D., & Pratiwi, E. (2026). Evaluasi kuantitatif penggunaan antipsikotik pada pasien skizofrenia dengan metode ATC/DDD dan DU 90% di RSJ Tampan Provinsi Riau tahun 2023. Jurnal SAGO Gizi dan Kesehatan, 7(2), 412. https://doi.org/10.30867/gikes.v7i2.3004

Vancouver

Sinata N, Tami DD, Pratiwi E. Evaluasi kuantitatif penggunaan antipsikotik pada pasien skizofrenia dengan metode ATC/DDD dan DU 90% di RSJ Tampan Provinsi Riau tahun 2023. Jurnal SAGO Gizi dan Kesehatan. 2026;7(2):412. doi:10.30867/gikes.v7i2.3004

BibTeX
@article{Sinata2026,
  author = {Sinata, Novia and Tami, Defrika Dian and Pratiwi, Erniza},
  title = {Evaluasi kuantitatif penggunaan antipsikotik pada pasien skizofrenia dengan metode ATC/DDD dan DU 90% di RSJ Tampan Provinsi Riau tahun 2023},
  journal = {Jurnal SAGO Gizi dan Kesehatan},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {412},
  doi = {10.30867/gikes.v7i2.3004}
}
Kostenlos starten →